drugset
drugset / Trial / NCT04708184

A Study to Assess Relative Bioavailability of and Effect of Food on a New Oral Tablet Formulation of GLPG3970

NCT04708184 ↗

Phase 1 Completed 12 enrolled Lakefront Biotherapeutics NV
RandomizedCrossoverOpen-labelTreatment

Summary

This is a study to assess the relative bioavailability of a GLPG3970 oral tablet formulation compared to an oral solution formulation and the effect of food on the bioavailability of a single dose of the oral tablet formulation of GLPG3970. It will also evaluate the safety and tolerability of a single dose of GLPG3970.

Timeline

Start
2021-01-11
Primary completion
2021-02-25
Completion
2021-02-25

Drugs

EvaluationDrugModalityDoseRoute
Subject GLPG3970 Unknown — Oral

Indications

No indication recorded.